Polycythemia Vera: Latest Updates for Patients & Caregivers in 2022 | Dr. Ruben Mesa | Blood Cancer

What is the latest in polycythemia vera or PV treatments and most promising clinical trials? This is what top MPNs specialist, Dr. Ruben Mesa, focuses on in this segment of our MPNs treatment in 2022 conversation with the exec. Director of the Mays Cancer Center, UT Health San Antonio MD Anderson.

Featuring: Dr. Ruben Mesa, Driector of UT Health San Antonio MD Anderson Cancer Center, Myeloproliferative Neoplasms (MPNs) Specialist

In this Series: Dr. Mesa covers the latest updates following the biggest blood cancer/disease conference (ASH) held at the end of 2021 that looked forward to emerging treatments studied in 2022 and beyond.

Full story & transcript → Updated Soon at www.ThePatientStory.com

Videos:
1) Essential Thrombocythemia Updates for Patients and Caregivers (2022):    • Essential Thrombocythemia: What Patients S...  
2) Polycythemia Vera: Latest Updates for Patients & Caregivers in 2022: This Video

The interview has only been edited for clarity.

Join Our Community:
Website : https://www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story

Contents of this video:
00:00 - Intro
00:13 - What to watch out for in polycythemia vera treatments in 2022
04:11 - The impact of iron deficiency on patients from phlebotomy
05:42 - Last message for PV patients and caregivers

____________________________

#ThePatientStory #bloodcancer #blooddisease #hematology #oncology #MPN #myeloproliferativeneoplasms #essentialthrombocythemia #polycythemiavera #clinicaltrials #relapsedrefractory #Patientcare #cancertreatment #Cartcelltherapy